Company Profile

ASTEC LIFESCIENCES LTD.

NSE : ASTECBSE : 533138ISIN CODE : INE563J01010Industry : Pesticides & AgrochemicalsHouse : Godrej
BSE1197.95-7.65 (-0.63 % )
PREV CLOSE (Rs.) 1205.60
OPEN PRICE (Rs.) 1239.25
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1409
TODAY'S LOW / HIGH (Rs.)1186.70 1242.95
52 WK LOW / HIGH (Rs.)306 1365
NSE1200.05 -15.45 (-1.27 % )
PREV CLOSE(Rs.) 1215.50
OPEN PRICE (Rs.) 1236.00
BID PRICE (QTY) 1200.05 (86 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 34977
TODAY'S LOW / HIGH(Rs.) 1186.00 1248.00
52 WK LOW / HIGH (Rs.)310 1367

Company News

Date Heading Details
18-Jan-2021 Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Monday, 25Th January, 2021 ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2021 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months' period ended 31st December, 2020 (subject to limited review by the Statutory Auditors of the Company), after these results are reviewed by the Audit Committee. In terms of Regulation 47 of the Listing Regulations, please find enclosed herewith, copies of the Notices of the Board Meeting published in newspapers, viz., Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language) today, i.e., on 18th January, 2021.
31-Dec-2020 Astec Lifesciences informs about trading window closure <div align="justify"><span>Astec Lifesciences has informed that as per the Companys Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed with effect from Friday, 1st January, 2021 till 48 (forty-eight) hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Nine Months ending 31st December, 2020. Accordingly all Officers and Designated Persons (including Directors and Auditors) of the Company have been intimated not to trade in (buy or sell) Equity Shares of the Company during the stated period.</span></div><font face="sans-serif"><span><div align="justify"><br></div></span></font><div align="justify"><font face="sans-serif"><span>The above information is a part of company's filings submitted to BSE.</span></font></div><div align="justify"><br></div>
21-Dec-2020 Announcement under Regulation 30 (LODR)-Change in Directorate This is to inform you that based on the recommendations of the Nomination and Remuneration Committee of the Board of Directors of the Company, the Board of Directors has, at its Meeting held today, i.e., on Friday, 18th December, 2020, appointed Mr. Nandkumar Vasant Dhekne [Director Identification Number (DIN): 02189370] and Ms. Anjali Rajesh Gupte [Director Identification Number (DIN): 00104884] as 'Additional Directors - Non-Executive & Independent' for a period of 5 (five) years with effect from 18th December, 2020 upto 17th December, 2025, subject to approval of the Shareholders of the Company.
18-Dec-2020 Appointment Of Mr. Nandkumar Vasant Dhekne (DIN This is to inform you that based on the recommendations of the Nomination and Remuneration Committee of the Board of Directors of the Company, the Board of Directors has, at its Meeting held today, i.e., on Friday, 18th December, 2020, appointed Mr. Nandkumar Vasant Dhekne [Director Identification Number (DIN): 02189370] and Ms. Anjali Rajesh Gupte [Director Identification Number (DIN): 00104884] as 'Additional Directors - Non-Executive & Independent' for a period of 5 (five) years with effect from 18th December, 2020 upto 17th December, 2025, subject to approval of the Shareholders of the Company.
19-Sep-2020 Astec LifeSciences informs about disclosure <p align="justify">Astec LifeSciences has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares &amp; Takeovers) Regulations, 2011 for Ashok V Hiremath.</p><p align="justify">The above information is a part of company's filings submitted to BSE.<br></p>
01-Sep-2020 Astec Lifesciences sells entire equity stake in Astec Europe Sprl <p align="justify">Astec Lifesciences has sold off its entire equity stake in Astec Europe Sprl and accordingly, Astec Europe Sprl ceases to be a subsidiary of the Company.<p align="justify">Astec Lifesciences manufactures a wide range of agrochemicals and pharmaceutical intermediates. With over two decades of experience in development and production of selected chemicals, the company has forged enduring relationships with large and small companies all over the world.</p>
26-Jun-2020 Astec Lifesciences informs about clarification on price movements <p align="justify">With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Astec Lifesciences has submitted a copy of clarification.</p><p align="justify">The above information is a part of company's filings submitted to BSE.</p>
18-May-2020 Astec LifeSciences informs about analsyt meet <p align="justify">Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Astec LifeSciences has informed that the schedule of analysts meet as on 18th May 2020 at 11.00 am with Nippon India Mutual Fund&nbsp; and Axis Capital in Mumbai. The aforesaid information is also being hosted on the website of the Company www.astecls.com.</p><p align="justify">The above information is a part of company's filings submitted to BSE.</p><p><br></p>